Results 201 to 210 of about 115,240 (299)

Risk of Crohn's disease in children presenting with perianal abscess and fistula increases with age: A multicenter study

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 5, Page 1226-1232, May 2026.
Abstract Objectives Perianal abscesses (PA) and fistulas‐in‐ano (FIA) are frequently diagnosed in children and may be presenting symptoms of Crohn's disease (CD). The association between age at presentation of PA/FIA and the risk of subsequent CD development is largely unknown.
Mariëlle Roskam, Thomas Dierikx, Sanne Hulsmann, Jesse Lemmen, Vanessa Leijdekkers, Joanna Luttikhold, Frank Garssen, Mich Dunker, Jarmila van der Bilt, Justin de Jong, Ernst van Heurn, Nanne de Boer, Roel Bakx, Tim de Meij   +13 more
wiley   +1 more source

Does Anemia Independently Influence the Erythrocyte Sedimentation Rate in Rheumatoid Arthritis? A Multivariate Analysis From North India. [PDF]

Cureus
Jindal A, Kaur K, Goel A, Setia P, Lanjewar S.   +4 more
europepmc   +1 more source

An 8-week, open-label, dose-finding study of nimodipine for the treatment of progranulin insufficiency from GRN gene mutations [PDF]

, 2017
et al,, Fagan, Anne M
core   +2 more sources

The In Vivo Erythrocyte Sedimentation Rate (ESR) Test: Pandemic Reemergence of Robin Fåhraeus’s “Fibrin Coagula”

In the pre-antibiotic era, infections were usually more frequent and serious than today. Robin Fåhraeus examined the erythrocyte sedimentation rate (ESR) test, which was normally carried out _in vitro _with freshly drawn blood. His extensive studies on the mechanism and physiological significance of the enhanced sedimentation of erythrocyte aggregates ...
openaire   +1 more source

Multicenter experience using tofacitinib for treatment of refractory pediatric inflammatory bowel diseases in the United States

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 5, Page 1218-1225, May 2026.
Abstract Objectives Tofacitinib is a selective Janus kinase (JAK‐1) inhibitor approved for the treatment of ulcerative colitis (UC) in adults. Data is limited in the pediatric population. The aim of this study was to evaluate the efficacy of tofacitinib in pediatric inflammatory bowel disease (IBD).
Denise D. Young, Jennifer E. Murphy, Mallory Chavannes, Jennifer L. Dotson, Jeanne Tung, Erica Chang, Brad Pasternak, Erin Crawford, Nancy McGreal, Jonathan Moses, Sandra C. Kim   +10 more
wiley   +1 more source

Erythrocyte Sedimentation Rate as a Monitoring Marker in the Canine Intensive Care Unit. [PDF]

J Vet Emerg Crit Care (San Antonio)
Gori E, Pasquini A, Briganti A, Diamanti D, Marchetti V.   +4 more
europepmc   +1 more source

Spinal Epidural Abscess [PDF]

, 2020
Luo, Christine T, Yee, Jennifer
core  

The micro erythrocyte sedimentation rate (ESR) in newborn babies.

Paediatrica Indonesiana, 1978
R, Sembiring, N, Raid, H, Siregar
openaire   +1 more source

Efficacy of upadacitinib induction for pediatric inflammatory bowel disease

JPGN Reports, Volume 7, Issue 2, Page 296-300, May 2026.
Abstract Objectives Upadacitinib, a second‐generation Janus kinase (JAK) inhibitor, is approved for moderate to severe Crohn's disease (CD) and ulcerative colitis (UC) in adults. Its efficacy in pediatric patients remains unclear, though early reports suggest benefits in refractory inflammatory bowel disease (IBD).
Evan Greenhall, Nina Gautam, Paula Prieto‐Jimenez, Elizabeth Hilow, Ashish Patel, Brad Pasternak   +5 more
wiley   +1 more source

Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests. [PDF]

Clinicoecon Outcomes Res
Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T.   +4 more
europepmc   +1 more source